New Zealand markets open in 6 hours 49 minutes

  • NZX 50

    11,736.75
    -34.52 (-0.29%)
     

  • NZD/USD

    0.6239
    -0.0014 (-0.22%)
     

  • ALL ORDS

    7,236.00
    +16.60 (+0.23%)
     

  • OIL

    74.12
    +0.92 (+1.26%)
     

  • GOLD

    1,965.00
    -8.50 (-0.43%)
     

World Respiratory Infection Diagnostic Market Research Report 2023: Syndromic Multiplexing, T.A.T, Antimicrobial Resistance Movement, and Pandemic Mitigation Augments Growth

Research and Markets
·5-min read
Company Logo
Company Logo

Dublin, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest.

Large new markets are opening up. In health facilities, clinics, physicians' offices and elsewhere. And let's not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well. Multiplex vs single plex? Explore the rapidly changing market as competitors jockey for position in new markets that are not yet well understood.

New technology is forever changing the diagnosis of respiratory infections. Shrinking time to result is opening up markets multiple times the size of current microbiology based practice. Diagnosis has already moved into the Emergency Room. It is now moving to the Physician's Office Lab. Could the Home be next?

The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress. The widespread nature of respiratory infections, (young people can get 8 colds a year) means that potential market sizes are enormous. Respiratory, already the largest infectious disease category could multiply in size. This is a growth opportunity for all diagnostic companies. Understand the opportunity and the risk with this in depth report.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Assistance, and additional specific data, is provided without additional charges.

Make investment decisions and valuations with confidence using the latest data with five year market forecasts.

Market Guides

  • Respiratory Infections Dx Market, Situation Analysis & Impact of COVID-19

  • Guide for Executives, Marketing, Sales and Business Development Staff

  • Guide for Management Consultants and Investment Advisors

Market Overview

Respiratory Infections

  • Upper vs. Lower - Marketing Implications

  • Understanding the Role of Pneumonia

  • Bacterial Infections

  • Tuberculosis - A Special Case

  • Viral Infections

  • COVID-19

  • Fungal and Other Pathogens

Diagnostics - A Changing Role

  • Historical Practice

  • Current Diagnostics

  • The Multiplex Vector

  • Future Diagnostics - The Question of When and Where

  • Respiratory Infection Diagnostics - The Destination

  • Diagnostics as Defensive Weapons

COVID-19

  • Pandemic Diagnostics

  • Risk Management - Spark and Spread

  • Dx Technology - Nucleic Acid Based

  • Dx Technology - Immunoassay & Serology

  • Time to Market and Preparedness Issues

  • Unrecognized Role of Multiplex in Pandemic Management

Market Trends

Factors Driving Growth

  • Syndromic Multiplexing

  • T.A.T

  • Antimicrobial Resistance Movement

  • Pandemic Mitigation

  • An Aging at Risk Population

Factors Limiting Growth

  • The Cost Curve

  • Regulation and coverage

  • Laissez Faire

Instrumentation and Automation

  • The Shrinking Multiplexing Machine

  • Bioinformatics Networking and Anonymous Reporting

Diagnostic Technology Development

  • The Key Role of Time to Result

  • Single Cell Genomics Changes the Picture

  • Pharmacogenomics Blurs Diagnosis and Treatment

  • Pathogen Identification - A Projected Timetable of the Future

Respiratory Infection Diagnostics Recent Developments

  • Genomtec Gets CE-IVD Mark for POC Respiratory Disease Test

  • FDA Issues First EUA for Non-Prescription COVID-19/Flu/RSV Test

  • "Diagnostics for the Real World" Plans Third-Generation POC Platform

  • Cue Health Targets DTC Market

  • Investors Skeptical of Ortho Clinical Diagnostics Acquisition by Quidel

  • Sense Biodetection to Debut Instrument-Free POC MDx

  • LGC Develops 'Ultra-High-Throughput' COVID Workflow

  • Cue Health Files for IPO for up to $100M

  • QuantuMDx Developing Multiplex System, Syndromic Panels

  • Bio-Rad Laboratories Gets CE Mark for Respiratory RT-PCR Assay Kit

  • BforCure Preparing Multiple Panels for PoC qPCR Platform

  • Angstrom Bio Raises $3M in Private Financing

  • Test for Them All

  • Hologic Banking on MDx Acquisitions

  • Pandemic Pushes Handheld qPCR Devices Closer to Commercialization

  • Talis Biomedical 2020 Revenues Rise Sharply

  • Luminex to Develop Covid/Flu/RSV Test

  • Becton Dickinson Charts Transition of COVID Diagnostics

  • MiRxes Receives Approval for Multiplex Covid/Flu Test

  • New Silicon-Based Test for Infectious Disease Screening

  • GenMark to Meet Demand for Respiratory Panel

  • Tempus Announces COVID-19 Testing, Data Initiative

  • Abacus Diagnostica Readying Multiplex Respiratory Test

  • Qiagen Acquires NeuMoDx Molecular

  • Companies Shift to Multiplex Tests for SARS-CoV-2, Influenza

  • Novacyt Gets CE Mark for Coronavirus, Flu, RSV Combo Panel

  • Cepheid Debuts 10-Color Technology With New Tuberculosis Test

  • BioMerieux's Pneumonia Panel Could Improve Care

  • Mammoth Biosciences Announces CRISPR-Based C19 Diagnostic

  • Genetic Signatures Gets CE Mark for C19 Molecular Test

  • Qiagen Respiratory Panel with C19 Receives CE Mark

  • Lumos Diagnostics Closes $15M Series A Funding

  • Fusion Genomics to Assess NGS Respiratory Tract Assay

  • C19 Test Development by Co-Diagnostics

  • Rapid Diagnostics Completes Purchase of Enigma Diagnostics

  • Flu-Like Epidemic Could Kill 80 Mn Globally

  • Startup developing AI for TB detection

  • Nipah Virus a Global Threat

Profiles of Key Players

  • Abacus Diagnostica

  • Abbott Laboratories

  • Accelerate Diagnostics

  • Access Bio

  • Ador Diagnostics

  • ADT Biotech

  • Akonni Biosystems

  • Altona Diagnostics

  • Alveo Technologies

  • Anatolia Geneworks

  • Antelope Dx

  • Applied BioCode

  • Assurance Scientific Laboratories

  • Aureum Diagnostics

  • Aus Diagnostics

  • Beckman Coulter Diagnostics

  • Becton, Dickinson and Company

  • Binx Health

  • Biocartis

  • BioFire Diagnostics (bioMerieux)

  • bioMerieux Diagnostics

  • Bio-Rad Laboratories, Inc.

  • Bosch Healthcare Solutions GmbH.

  • Celemics

  • Cepheid (Danaher)

  • Chembio

  • Co Diagnostics

  • Credo Diagnostics Biomedical

  • Cue Health

  • Curetis N.V./Curetis GmbH

  • Detect

  • Diagenode Diagnostics

  • Diascopic

  • Diasorin S.p.A.

  • Enzo Biochem

  • Eurofins Scientific

  • Fluxergy

  • Fulgent Genetics

  • Fusion Genomics.

  • Genetic Signatures

  • GenMark Dx (Roche)

  • Hibergene Diagnostics

  • Hologic

  • Immunexpress

  • Inflammatix

  • Invetech

  • Janssen Diagnostics

  • Karius

  • Lexagene

  • LightDeck Diagnostics

  • Luminex Corp

  • Lumos Diagnostics

  • Mammoth Biosciences

  • Maxim Biomedical

  • Meridian Bioscience

  • Mesa Biotech (Thermo Fisher)

  • Millipore Sigma

  • Mindray

  • Mobidiag (Hologic)

  • Mologic

  • Nanomix

  • Operon

  • Oxford Nanopore Technologies

  • Panagene

  • Perkin Elmer

  • Prenetics

  • Primerdesign (Novacyt)

  • Prominex

  • Qiagen

  • QuantuMDx

  • Quidel

  • Roche Molecular Diagnostics

  • Seegene

  • Siemens Healthineers

  • Sona Nanotech

  • SpeeDx

  • T2 Biosystems

  • Talis Biomedical

  • Thermo Fisher Scientific Inc.

  • Veramarx

  • Veredus Laboratories

  • Visby Medical

  • XCR Diagnostics

  • Zhejiang Orient Gene Biotech

For more information about this report visit https://www.researchandmarkets.com/r/azaj06

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Latest stories

  • Is It Too Late to Buy Airbnb?

    Airbnb (NASDAQ: ABNB) stock is back in Wall Street's good graces. A quick rally like that might convince many investors to look elsewhere to find an attractive growth stock. Airbnb's platform could have many years of strong growth ahead as more hosts move onto the platform and more people book rooms, homes, and apartments for short-term -- and sometimes long-term -- stays.

  • IBM Cloud Direct Link Now Available on Cologix Access Marketplace

    Partnership Provides Direct Link to Cologix Customers in Ashburn, Columbus, Montréal and Toronto IBM Cloud Direct Link on Cologix Access Marketplace IBM Cloud Direct Link Now Available on Cologix Access Marketplace for customers in Ashburn, Columbus, Montréal and Toronto. DENVER, March 29, 2023 (GLOBE NEWSWIRE) -- Cologix, North America’s leading network-neutral interconnection and hyperscale edge data center company, today announced that IBM Cloud Direct Link is now available on Cologix Access

  • Anti Stretch Mark Products Global Market Report 2023

    Major players in the anti-stretch mark products market are Clarinis, E.T Browne Drug Co., Himalaya Global Holdings Ltd., Basq Skin Care, Weleda AG, Dermaclara Inc., Mama Mio, Mustela, Crown Laboratories, Inc.New York, March 29, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Anti Stretch Mark Products Global Market Report 2023" - https://www.reportlinker.com/p06317630/?utm_source=GNW , Earth Mama Organics, Union Swiss Ltd., The Clorox Company (Burt’s Bees), Vichy L

  • First Quantum Minerals Ltd.'s (TSE:FM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

    First Quantum Minerals' (TSE:FM) stock up by 4.6% over the past month. Given that stock prices are usually aligned with...

  • Lil Nas X doesn't like dating famous people

    Lil Nas X hates dating other famous people. The 'Montero' hitmaker used to use exclusive dating app Raya in his quest to find love but he's now stopped using his account because all the other users were well known and he's learned from previous experience that he doesn't want to go out with another star. Speaking during the 'Carpool Karaoke' segment on 'The Late Late Show', he told host James Corden: “I used to use Raya. I think I stopped using Raya… It just like, fell off for me and I just star

  • Grief-stricken Ana Obregon welcomes new baby at 68 after son's tragic death

    Ana Obregon is a new mum at 68 after welcoming a daughter via surrogate. Hola! magazine reports the baby girl was born in Miami, Florida on March 20 - just two days after the veteran Spanish actress/TV celebrated her 68th birthday - and Ana is said to have flown to the US before the birth and rented an apartment in Miami where she can spend time with the tot. She was pictured leaving the hospital with the newborn in her arms, but Ana has yet to publicly comment on her happy news. The magazine re

  • Demi Lovato pays gushing tribute to boyfriend on his birthday

    Demi Lovato "couldn't be more in love" with Jute$. The 30-year-old singer paid a heartfelt tribute to her partner in honour of the musician's 32nd birthday on Tuesday (28.03.23), and hailed her boyfriend a "literal dream come true". Alongside a series of candid photos of the couple, Demi wrote on Instagram: "My sweet angel - it’s officially your birthday!!! I couldn’t be more excited to celebrate you because I couldn’t be more in love with your gorgeous, funny, sexy, talented self. "I’ve waited

  • Jeremy Renner to return to work for first time since snowplough accident

    Jeremy Renner is returning to work for first time since his snowplough accident by attending the premiere of his new TV show. The 52-year-old actor cheated death when he was crushed by his 14,000-lb Pistenbully Snowcat while helping his nephew free his car close to his home in Nevada on New Year's Day (01.01.23) and he spent weeks in hospital recovering from injuries which included 30 broken bones - but he has since returned home and was recently seen walking again with the help of a specialist

  • AMC stock jumps on reported Amazon acquisition

    Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss reports that Amazon is interested in acquiring AMC.

  • Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification

    SAN FRANCISCO, March 29, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has completed the supplier qualification and first article inspection of Microart Services, Inc., one of two new partners announced in Q4 of 2022.

  • Is Extreme Networks, Inc. (NASDAQ:EXTR) A High Quality Stock To Own?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • LCS Named 2023 Gallup Exceptional Workplace Winner

    LCS is one of only 57 companies selected by Gallup to receive an Exceptional Workplace Award this year Gallup Exceptional Workplace Award Logo 2023 Gallup Logo LCS Logo LCS Named a Gallup Exceptional Workplace DES MOINES, Iowa, March 29, 2023 (GLOBE NEWSWIRE) -- LCS, the nation’s third largest senior living provider, has been selected as a 2023 Gallup Exceptional Workplace Award (GEWA) honoree. This is the first time LCS has been selected for Gallup’s invitation-only award that recognizes the mo

  • Catalyst Fertilizer Global Market Report 2023

    Major players in the catalyst fertilizers market are Clariant International Ltd., Johnson Matthey, Haldor Topsoe India Private Ltd., QuantumSphere Inc., Chempack, China Petroleum & Chemical Corporation, ThyssenKrupp AG, BASF SE, Casale SA, Mmcité, Project & Development India Ltd.New York, March 29, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Catalyst Fertilizer Global Market Report 2023" - https://www.reportlinker.com/p06317638/?utm_source=GNW , LKAB Minerals L

  • Is Now An Opportune Moment To Examine Advanced Micro Devices, Inc. (NASDAQ:AMD)?

    Today we're going to take a look at the well-established Advanced Micro Devices, Inc. ( NASDAQ:AMD ). The company's...

  • Uber Technologies (NYSE:UBER) Is Carrying A Fair Bit Of Debt

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • 2 Reasons I'm Keeping Some of My Retirement Savings in a Brokerage Account -- and Getting No Tax Benefits

    Because I write about retirement on a daily basis, I'm well aware that planning to retire on Social Security alone is not a great idea. In doing so, I give up the tax benefits associated with IRAs and 401(k)s. But it makes sense to do so for these reasons. The money you contribute to a traditional IRA or 401(k) goes in tax free.

  • Investing in Polaris (NYSE:PII) three years ago would have delivered you a 148% gain

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a...

  • DECISIONS OF RAPALA VMC CORPORATION’S ANNUAL GENERAL MEETING AND ORGANISING MEETING OF THE BOARD OF DIRECTORS

    RAPALA VMC CORPORATION, Decisions of general meeting, March 29, 2023 at 5:00 p.m. EET The Annual General Meeting (AGM) of Rapala VMC Corporation has on 29 March 2023 adopted the financial statement of the financial year 2022 and discharged the members of the Board of Directors and the CEO from liability for the financial year that ended on 31 December 2022. The AGM approved the remuneration report for governing bodies for the financial year 2022. The AGM approved the Board of Director’s proposal

  • Cirrus Aircraft Launches Aircraft Configurator

    DULUTH, Minn. & KNOXVILLE, Tenn., March 29, 2023--Cirrus Aircraft today launched its aircraft configurator, a web-based digital tool, that allows customers to comprehensively explore the company's world-class SR Series and Vision Jet® then select from a rich exterior color palette and premium leather interior to further tailor the aircraft inside a dedicated hangar. The configurator inspires people to learn more about the unparalleled aircraft product line, advanced features and invites them to

  • Santander US Research Reveals Middle-Income Americans Are Optimistic about Achieving Financial Prosperity

    BOSTON, March 29, 2023--Santander Holdings USA, Inc. ("Santander US") today announced findings from a new survey of middle-income Americans, which revealed that 86% of respondents believe financial prosperity remains a worthwhile goal, with 79% optimistic that they will achieve it within the next decade, despite current headwinds.